Description

4H-Pyrrolo[3,2,1-Ij]Quinoline-1-Propanamine,5,6-Dihydro-(9Ci) is a high-purity, advanced pharmaceutical intermediate belonging to a class of fused heterocyclic compounds. This compound is valued for its complex molecular architecture, which serves as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily sought by research institutions and pharmaceutical manufacturers engaged in the development of new therapeutic agents, particularly within the fields of oncology and central nervous system (CNS) disorders.

Application

• Pharmaceutical Intermediate: A key precursor in the multi-step synthesis of complex drug candidates and novel chemical entities.
• Organic Synthesis Building Block: Used in research and development for constructing complex fused-ring systems in medicinal chemistry.
• Life Science Research: Employed in biochemical and pharmacological studies to investigate structure-activity relationships (SAR).
• Agrochemical Development: Potential use as an intermediate in the synthesis of advanced crop protection agents.
• Material Science Research: Investigated for the development of organic electronic materials due to its conjugated heterocyclic structure.

Basic Information

Product Name	4H-Pyrrolo[3,2,1-Ij]Quinoline-1-Propanamine,5,6-Dihydro-(9Ci)
CAS No.	586336-42-7
Molecular Formula	C₁₄H₁₈N₂
Molecular Weight	214.31 g/mol
Synonyms	5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinoline-1-propanamine; 1-Propanamine, 5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinoline-; 4H-Pyrrolo[3,2,1-ij]quinoline-1-propanamine, 5,6-dihydro-; (9Ci) 586336-42-7; Fused tricyclic quinoline derivative; Pyrroloquinoline propanamine derivative
EINECS	Contact for details

Quality Control

Our production of 4H-Pyrrolo[3,2,1-Ij]Quinoline-1-Propanamine,5,6-Dihydro-(9Ci) adheres to stringent quality management protocols. Each batch undergoes comprehensive analytical testing, including HPLC for purity and NMR for structural confirmation, to ensure it meets the exacting standards required for pharmaceutical R&D. A Certificate of Analysis (COA) detailing all specifications is provided with every shipment to guarantee traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). The material should be kept under an inert atmosphere if long-term storage is required to prevent potential degradation.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Residual Solvents (GC)	Complies with ICH guidelines
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.